This page shows the latest infections news and features for those working in and with pharma, biotech and healthcare.
aim of developing new drugs for bacterial, viral, fungal and parasitic infections.
The latest data was reported at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.
According to Novo, more than 700, 000 people die each year from infections resistant to most or all antibiotics, and by 2050 antimicrobial resistance is projected to end more lives than
It is designed to exert its activity primarily within the GI tract with limited systemic uptake - potentially reducing side effects associated with drugs in the class such as infections, liver damage,
Zavicefta is already approved in Europe for HABP/VABP. One of the key roles for the new product is in the treatment of infections with carbapenem-resistant Enterobacteriaceae (CRE). ... Gram-negative pathogens are some of the most pressing antibiotic
More from news
Approximately 11 fully matching, plus 874 partially matching documents found.
This global research, looking at 13, 000 patients across 66 countries, found that over 12% of those undergoing procedures developed a post-operative surgical site infection (SSI). ... After all, so many of today’s life-saving healthcare advances, from
learning anatomy, practising operations or even teaching infection control.
NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis. ... Its novel therapy is an inhaled formulation of
Asymptomatic. Showing no signs of a disease or infection.
However, rates of infection in the gay community dropped following the campaign.
More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.
Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer Schranz.
Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... I am looking forward to working with
patients suffering from serious infections such as influenza to get better, faster.
surgical infections from all strains of Staphylococcus aureus, which we believe is a blockbuster opportunity.”.
Allecra’s technology provides an important new treatment for hospital clinicians who are grappling with these types of infection.”. ... Hooftman’s new role will see him focus on combating multi drug-resistant Gram-negative bacterial infections.
More from appointments
Approximately 1 fully matching, plus 20 partially matching documents found.
The patient had a persistent chest infection and her GP had prescribed more antibiotics and sent her for an X-ray. ... Sadly it wasn’ t just a chest infection, and without Aine’ s intervention it could have taken a long time for it to come to our
For example, the report found that urinary tract infections accounted for 14 percent of emergency admissions for MS in 2015/16 and they cost £2, 639 per patient; while respiratory issues ... Preventative care strategies for people with MS must be
Pharma could also identify new issues. For example, NHiS identified a huge number of emergency hospital admissions for urinary tract infections in several NHS Clinical Networks which led to a review
Also, it’ s often safer for patients to receive treatment at home to avoid iatrogenic diseases, for example, infections in immune-suppressed patients.
Similarly, they do not know where improvements and cost-savings could be made by, for example, treating recurrent infections in patients suffering from diseases such as multiple sclerosis at primary care
More from PMHub
Approximately 1 fully matching, plus 21 partially matching documents found.
No results were found
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...